Hazard Hub

Dosage Recalls in Canada

12 recalls involving dosage — most are other recalls. Newest first, updated daily from government open data.

Showing 1–12 of 12

Health Products Type III
2026-02-26

Champignons et Adaptogènes: Affected lot contains concentrations for certain ingredients that differ from the concentration on the label.

Dosage

View recall details →

Other
2025-03-17

Importation of US-Authorized BESREMi (Ropeginterferon alfa-2b-njft) Injection Due to the Current Shortage of Canadian-Authorized PEGASYS (Peginterferon alfa-2a) Injection

Supply - Dosage - Labelling - Packaging

View recall details →

Other
2024-10-23

Importation of US-Authorized Methotrexate for Injection, USP Due to the Current Shortage of Canadian-Authorized Methotrexate Injection BP, 25 mg/mL

Supply - Dosage - Packaging

View recall details →

Other
2024-09-05

All lots of JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets recalled due to possible incorrect dose, which may pose health risks

Product safety - Dosage

View recall details →

Other
2024-08-29

Importation of US-authorized Epinephrine Injection USP, 1 mg/10 mL Single-Dose Pre-Filled Syringes Due to the Current Shortage of Canadian-Authorized Epinephrine Injection USP, 1 mg/10 mL Single-Use Syringes

Supply - Dosage - Packaging

View recall details →

Health Products Type III
2024-02-20

Nutracelle Nutramin Vitamin for Kids : Affected lot contains Vitamin B6 and Folate levels outside of the labelled claim.

Dosage

View recall details →

Other
2023-03-03

Cannabis edibles incorrectly sold as cannabis extracts may lead to overconsumption of Delta-9-tetrahydrocannabinol (THC)

Labelling and packaging - Dosage

View recall details →

Health Products Type I
2022-08-29

JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.

Dosage - Labelling

View recall details →

Other
2022-08-27

Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets

Dosage - Labelling

View recall details →

Health Products Type I
2022-08-22

PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose

Adverse reaction - Dosage - Labelling - Packaging - Product safety - Product withdrawal

View recall details →

Other
2022-08-20

Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose

Adverse reaction - Dosage - Labelling - Packaging - Product safety - Product withdrawal

View recall details →

Health Products Type III
2022-07-13

Recall of 99.0% Oxygen USP cylinders

Dosage

View recall details →

Other Other Hazards

Unauthorized product (136)New safety information (39)Supply (28)Undeclared substance (19)Microbial contamination (18)Suspected quality concern (13)Adverse reaction (10)Product withdrawal (6)

Browse all recalls by hazard, allergen & year →